Decentralized Clinical Trials: A Guide to Connected Health Telemetry
Explosive growth in connected health has been mostly seen in remote patient monitoring and virtual healthcare visits, while other areas moving towards digitization include decentralized clinical trials (DCTs).
Decentralized clinical trials are an area of connected health positioned to see explosive growth in coming years. With a greater ability to collect more accurate data, widen patient pools, and bring treatments to market faster, it makes good business sense to adopt this IoT healthcare approach. But finding the right IoT solutions partner is crucial to success.
Healthcare rapidly adopted digital solutions during the pandemic, with investments skyrocketing in 2020 by more than triple than had been seen in previous years, according to McKinsey & Company research. And while the McKinsey & Company research continues by stating digital healthcare has decreased since the peak of the pandemic, it has stabilized at levels 38 times higher than before the pandemic.
Explosive growth in connected health has been mostly seen in remote patient monitoring and virtual healthcare visits, while other areas moving towards digitization include decentralized clinical trials (DCTs). According to a 2020 survey of clinical trial professionals by Informa Connect, decentralized and virtual trials still represent less than half of clinical research, with roughly one-quarter of ongoing trials incorporating DCT components. One of the reasons behind that is the complexity of building out a connected health solution, which is enabled by IoT.
This eBook provides a mini guide to connected health telemetry and dives into the market and benefits of decentralized clinical trials, key challenges and how to overcome them, and how KORE helped Clinical Ink deploy, manage, and scale clinical trial solutions.